{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:33:38Z","timestamp":1788910418941,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.compbiomed.2022.105523","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T18:56:34Z","timestamp":1650048994000},"page":"105523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["In silico evaluation of atazanavir as a potential HIV main protease inhibitor and its comparison with new designed analogs"],"prefix":"10.1016","volume":"145","author":[{"given":"Mehdi","family":"Yoosefian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Zeraati","family":"Moghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2022.105523_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2796.2008.02043.x","article-title":"Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?","volume":"265","author":"Boasso","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.compbiomed.2022.105523_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1039\/b208248a","article-title":"HIV-1 protease: mechanism and drug discovery","volume":"1","author":"Brik","year":"2003","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.compbiomed.2022.105523_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11481-011-9315-2","article-title":"IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS","volume":"7","author":"Yannam","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.compbiomed.2022.105523_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/1744666X.2018.1459571","article-title":"Relationship between human immunodeficiency virus (HIV-1) infection and chronic periodontitis","volume":"14","author":"P\u00f3lvora","year":"2018","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.compbiomed.2022.105523_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001249","article-title":"Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure","volume":"6","author":"White","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.compbiomed.2022.105523_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrmicro2747","article-title":"The structural biology of HIV-1: mechanistic and therapeutic insights","volume":"10","author":"Engelman","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.compbiomed.2022.105523_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2217\/fvl.10.43","article-title":"Retroviruses: molecular biology, genomics and pathogenesis","volume":"5","author":"Telesnitsky","year":"2010","journal-title":"Future Virol."},{"key":"10.1016\/j.compbiomed.2022.105523_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tim.2008.09.006","article-title":"Live cell imaging of the HIV-1 life cycle","volume":"16","author":"Campbell","year":"2008","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.compbiomed.2022.105523_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/mi.2007.1","article-title":"HIV infection and the gastrointestinal immune system","volume":"1","author":"Brenchley","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.compbiomed.2022.105523_bib10","first-page":"95","article-title":"HIV protease inhibitors: a review of molecular selectivity and toxicity","volume":"7","author":"Lv","year":"2015","journal-title":"Hiv\/aids (Auckland, NZ)"},{"key":"10.1016\/j.compbiomed.2022.105523_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.virusres.2008.01.003","article-title":"Novel HIV-1 reverse transcriptase inhibitors","volume":"134","author":"Jochmans","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.compbiomed.2022.105523_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nrd1660","article-title":"Integrase inhibitors to treat HIV\/AIDS","volume":"4","author":"Pommier","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiomed.2022.105523_bib13","doi-asserted-by":"crossref","first-page":"10226","DOI":"10.1128\/JVI.76.20.10226-10233.2002","article-title":"Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease","volume":"76","author":"Pettit","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.compbiomed.2022.105523_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0006-291X(88)80839-8","article-title":"HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins","volume":"156","author":"Darke","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.compbiomed.2022.105523_bib15","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/anie.200604087","article-title":"Convergent chemical synthesis and crystal structure of a 203 amino acid \u201ccovalent dimer\u201d HIV\u20101 protease enzyme molecule","volume":"46","author":"Torbeev","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.compbiomed.2022.105523_bib16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2174\/1568026043388312","article-title":"Non-peptidic HIV protease inhibitors","volume":"4","author":"Chrusciel","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.compbiomed.2022.105523_bib17","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1128\/JVI.78.16.8477-8485.2004","article-title":"Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism","volume":"78","author":"Pettit","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.compbiomed.2022.105523_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.biochi.2015.08.009","article-title":"HIV-1 protease substrate-groove: role in substrate recognition and inhibitor resistance","volume":"118","author":"Laco","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.compbiomed.2022.105523_bib19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00003495-200969080-00009","article-title":"Atazanavir: a review of its use in the management of HIV-1 infection","volume":"69","author":"Croom","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.compbiomed.2022.105523_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2217\/fvl.10.89","article-title":"Atazanavir\/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults","volume":"6","author":"Achenbach","year":"2011","journal-title":"Future Virol."},{"key":"10.1016\/j.compbiomed.2022.105523_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1054-3589(07)55008-8","article-title":"HIV\u20101 protease: structure, dynamics, and inhibition","volume":"55","author":"Louis","year":"2007","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.compbiomed.2022.105523_bib22","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1086\/386291","article-title":"Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens","volume":"189","author":"Colonno","year":"2004","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.compbiomed.2022.105523_bib23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1128\/AAC.47.4.1324-1333.2003","article-title":"Activities of atazanavir (BMS-232632) against a large panel of human immunodeficiency virus type 1 clinical isolates resistant to one or more approved protease inhibitors","volume":"47","author":"Colonno","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.compbiomed.2022.105523_bib24","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/acschemneuro.8b00729","article-title":"How does chirality determine the selective inhibition of histone deacetylase 6? A lesson from trichostatin a enantiomers based on molecular dynamics","volume":"10","author":"Zhang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.compbiomed.2022.105523_bib25","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/acschemneuro.7b00173","article-title":"Differentiating physicochemical properties between addictive and nonaddictive ADHD drugs revealed by molecular dynamics simulation studies","volume":"8","author":"Wang","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.compbiomed.2022.105523_bib26","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acschemneuro.7b00490","article-title":"What contributes to serotonin\u2013norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation","volume":"9","author":"Xue","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.compbiomed.2022.105523_bib27","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/acs.jcim.8b00261","article-title":"Steered molecular dynamics simulation in rational drug design","volume":"58","author":"Do","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2022.105523_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpha.2020.04.008","article-title":"Structural elucidation of SARS-CoV-2 vital proteins: computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase","volume":"10","author":"Mirza","year":"2020","journal-title":"J. pharm. anal."},{"key":"10.1016\/j.compbiomed.2022.105523_bib29","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2022.105523_bib30","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/JVI.03486-12","article-title":"Structural and thermodynamic basis of amprenavir\/darunavir and atazanavir resistance in HIV-1 protease with mutations at residue 50","volume":"87","author":"Mittal","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.compbiomed.2022.105523_bib31","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2022.105523_bib32","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool, CCP4 Newsl","volume":"40","author":"DeLano","year":"2002","journal-title":"Protein Crystallogr."},{"key":"10.1016\/j.compbiomed.2022.105523_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug\u2010like molecules compatible with the CHARMM all\u2010atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2022.105523_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.compbiomed.2022.105523_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.compbiomed.2022.105523_bib36","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2022.105523_bib37","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5 log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2022.105523_bib38","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.bbagen.2017.07.022","article-title":"Differentiating physicochemical properties between NDRIs and sNRIs clinically important for the treatment of ADHD","volume":"1861","author":"Wang","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.compbiomed.2022.105523_bib39","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1039\/C7CP07869B","article-title":"Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder","volume":"20","author":"Xue","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2022.105523_bib40","doi-asserted-by":"crossref","first-page":"24125","DOI":"10.1039\/D1CP02157E","article-title":"Exploring the binding mechanism of positive allosteric modulators in human metabotropic glutamate receptor 2 using molecular dynamics simulations","volume":"23","author":"Wang","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2022.105523_bib41","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa-A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2022.105523_bib42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/minf.201100135","article-title":"Free energy calculations by the molecular mechanics Poisson\u2212 Boltzmann surface area method","volume":"31","author":"Homeyer","year":"2012","journal-title":"Molecul. inform."},{"key":"10.1016\/j.compbiomed.2022.105523_bib43","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0022-2836(03)00610-7","article-title":"Insights into protein\u2013protein binding by binding free energy calculation and free energy decomposition for the Ras\u2013Raf and Ras\u2013RalGDS complexes","volume":"330","author":"Gohlke","year":"2003","journal-title":"J. Mol. Biol."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482522003158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482522003158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T19:55:32Z","timestamp":1757879732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482522003158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":43,"alternative-id":["S0010482522003158"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105523","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico evaluation of atazanavir as a potential HIV main protease inhibitor and its comparison with new designed analogs","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105523"}}